Silo Pharma Inc (SILO)

US · Healthcare · Biotechnology

$1.72-2.27%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Revenue YoY

-100.0%

Net profit

$-832,829

EPS

$-0.76

Market cap

$3.7M

Forward P/E

0.0

P/B

0.77

Book value

$4.33

EPS (TTM)

$-3.65

52-week high

$15.15

52-week low

$2.10

50-day MA

$4.06

200-day MA

$5.41

Beta

0.75

Analysts rate Silo Pharma Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.00.

Insiders

11.72%

Institutions

8.16%

Fund	Stake
AdvisorShares Investments, LLC	4.76%
Geode Capital Management, LLC	0.76%
Susquehanna International Group, LLP	0.26%
Jane Street Group LLC	0.19%
Citadel Advisors Llc	0.09%
XTX Topco Ltd	0.07%
TWO SIGMA SECURITIES, LLC	0.06%
Vanguard Fiduciary Trust Co	0.06%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Silo Pharma Inc — free to start.

Data updated 2026-09-18.